Skip to main content
Back to News Hub
🤝Crunchbase M&A
November 17, 2026
Funding & Investment

PwC's IPO Lead On A Selective Market, AI Valuations And The Outlook For 2027

Overview

He addressed the recent deceleration in initial public offering activity alongside the criteria public investors use when assessing artificial intelligence firms. Bellin also examined the resurgence of biotech businesses and the reasons special purpose acquisition companies are drawing fresh attention.

Key Takeaways

  • On November 17, 2026, Crunchbase M&A featured a Q&A with Mike Bellin, a partner and U.S. IPO services leader at PricewaterhouseCoopers.

    Bellin offered his perspective on the recent deceleration in initial public offering activity and explained how public investors are currently analyzing artificial intelligence businesses.

  • His insights highlight a cautious public market environment where technology valuations face increased scrutiny.

    Beyond technology and artificial intelligence valuations, the discussion covered broader shifts in corporate financing.

  • Bellin noted a resurgence within the biotech sector and discussed why special purpose acquisition companies are gaining renewed traction among investors.

    For observers tracking technology commercialization, these trends illustrate how alternative funding structures and sector-specific rebounds shape the public market landscape.

  • Mike Bellin, a partner and U.S. IPO services leader at PricewaterhouseCoopers, analyzed key capital market trends in a recent interview.

    Public investors are adopting specific evaluation methods when reviewing artificial intelligence companies for potential listings.

  • The market is seeing a deceleration in initial public offering momentum alongside renewed interest in special purpose acquisition companies.
PwC's IPO Lead On A Selective Market, AI Valuations And The Outlook For 2027

On November 17, 2026, Crunchbase M&A featured a Q&A with Mike Bellin, a partner and U.S. IPO services leader at PricewaterhouseCoopers. Bellin offered his perspective on the recent deceleration in initial public offering activity and explained how public investors are currently analyzing artificial intelligence businesses. His insights highlight a cautious public market environment where technology valuations face increased scrutiny.

Beyond technology and artificial intelligence valuations, the discussion covered broader shifts in corporate financing. Bellin noted a resurgence within the biotech sector and discussed why special purpose acquisition companies are gaining renewed traction among investors. For observers tracking technology commercialization, these trends illustrate how alternative funding structures and sector-specific rebounds shape the public market landscape.

Mike Bellin, a partner and U.S. IPO services leader at PricewaterhouseCoopers, analyzed key capital market trends in a recent interview. Public investors are adopting specific evaluation methods when reviewing artificial intelligence companies for potential listings. The market is seeing a deceleration in initial public offering momentum alongside renewed interest in special purpose acquisition companies.

For more details please read the original article at Crunchbase M&A.

Continue Learning

Comments

Comments appear only after moderation. Your email identifies your submission to the moderator and is never displayed here.

No approved comments yet.

Originally published by Crunchbase M&A
Read the original